Delaware has seen a 65% increase in new biotechnology companies over the past decade, according to a recent report by the Delaware BioScience Association and the Delaware Prosperity Partnership. This ...
We used to say data is the new oil. In commercial life sciences, context has become oxygen. AI can read millions of pages, extract structure from chaos and turn scattered trial data, clinical notes ...
Drug development and commercialization leads to tremendous advances in medicine and improvements to everyday life, but it often comes at a cost. Delayed clinical trials, regulatory approvals, and ...